136 related articles for article (PubMed ID: 27039831)
21. Development and evaluation of glyburide fast dissolving tablets using solid dispersion technique.
Valleri M; Mura P; Maestrelli F; Cirri M; Ballerini R
Drug Dev Ind Pharm; 2004 May; 30(5):525-34. PubMed ID: 15244088
[TBL] [Abstract][Full Text] [Related]
22. Improvement of dissolution and oral absorption of ER-34122, a poorly water-soluble dual 5-lipoxygenase/cyclooxygenase inhibitor with anti-inflammatory activity by preparing solid dispersion.
Kushida I; Ichikawa M; Asakawa N
J Pharm Sci; 2002 Jan; 91(1):258-66. PubMed ID: 11782915
[TBL] [Abstract][Full Text] [Related]
23. Design, optimization, preparation and evaluation of dispersion granules of valsartan and formulation into tablets.
Shrivastava AR; Ursekar B; Kapadia CJ
Curr Drug Deliv; 2009 Jan; 6(1):28-37. PubMed ID: 19418953
[TBL] [Abstract][Full Text] [Related]
24. Effects of wet-granulation process parameters on the dissolution and physical stability of a solid dispersion.
Kinoshita R; Ohta T; Shiraki K; Higashi K; Moribe K
Int J Pharm; 2017 May; 524(1-2):304-311. PubMed ID: 28389363
[TBL] [Abstract][Full Text] [Related]
25. Tablet formulation studies on an oxcarbazepine-beta cyclodextrin binary system.
Patel NV; Chotai NP; Patel MP
Pharmazie; 2008 Apr; 63(4):275-81. PubMed ID: 18468386
[TBL] [Abstract][Full Text] [Related]
26. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.
Zhaojie M; Ming Z; Shengnan W; Xiaojia B; Hatch GM; Jingkai G; Li C
Int J Pharm; 2014 Jun; 467(1-2):50-9. PubMed ID: 24607213
[TBL] [Abstract][Full Text] [Related]
27. Solid self-microemulsifying drug delivery system of ritonavir.
Deshmukh A; Kulkarni S
Drug Dev Ind Pharm; 2014 Apr; 40(4):477-87. PubMed ID: 23465049
[TBL] [Abstract][Full Text] [Related]
28. Impact of chitosan as a disintegrant on the bioavailability of furosemide tablets: in vitro evaluation and in vivo simulation of novel formulations.
Rasool BK; Fahmy SA; Galeel OW
Pak J Pharm Sci; 2012 Oct; 25(4):815-22. PubMed ID: 23009999
[TBL] [Abstract][Full Text] [Related]
29. Enhanced dissolution and bioavailability of grapefruit flavonoid Naringenin by solid dispersion utilizing fourth generation carrier.
Khan AW; Kotta S; Ansari SH; Sharma RK; Ali J
Drug Dev Ind Pharm; 2015 May; 41(5):772-9. PubMed ID: 24669978
[TBL] [Abstract][Full Text] [Related]
30. Application of spherical silicate to prepare solid dispersion dosage forms with aqueous polymers.
Nagane K; Kimura S; Ukai K; Takahashi C; Ogawa N; Yamamoto H
Int J Pharm; 2015 Sep; 493(1-2):55-62. PubMed ID: 26200750
[TBL] [Abstract][Full Text] [Related]
31. Effect of drug-carrier interaction on the dissolution behavior of solid dispersion tablets.
Srinarong P; Kouwen S; Visser MR; Hinrichs WL; Frijlink HW
Pharm Dev Technol; 2010; 15(5):460-8. PubMed ID: 20735300
[TBL] [Abstract][Full Text] [Related]
32. Development of a rapidly dispersing tablet of a poorly wettable compound: formulation DOE and mechanistic study of effect of formulation excipients on wetting of celecoxib.
He X; Barone MR; Marsac PJ; Sperry DC
Int J Pharm; 2008 Apr; 353(1-2):176-86. PubMed ID: 18207339
[TBL] [Abstract][Full Text] [Related]
33. Adsorption of meloxicam on porous calcium silicate: characterization and tablet formulation.
Sharma S; Sher P; Badve S; Pawar AP
AAPS PharmSciTech; 2005 Dec; 6(4):E618-25. PubMed ID: 16408863
[TBL] [Abstract][Full Text] [Related]
34. Ion release, porosity, solubility, and bioactivity of MTA Plus tricalcium silicate.
Gandolfi MG; Siboni F; Primus CM; Prati C
J Endod; 2014 Oct; 40(10):1632-7. PubMed ID: 25260736
[TBL] [Abstract][Full Text] [Related]
35. The dissolution enhancement of piroxicam in its physical mixtures and solid dispersion formulations using gluconolactone and glucosamine hydrochloride as potential carriers.
Al-Hamidi H; Obeidat WM; Nokhodchi A
Pharm Dev Technol; 2015 Jan; 20(1):74-83. PubMed ID: 24392858
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of three chitin metal silicate co-precipitates as a potential multifunctional single excipient in tablet formulations.
Hamid RA; Al-Akayleh F; Shubair M; Rashid I; Remawi MA; Badwan A
Mar Drugs; 2010 May; 8(5):1699-715. PubMed ID: 20559493
[TBL] [Abstract][Full Text] [Related]
37. Cefuroxime axetil solid dispersion with polyglycolized glycerides for improved stability and bioavailability.
Dhumal RS; Biradar SV; Aher S; Paradkar AR
J Pharm Pharmacol; 2009 Jun; 61(6):743-51. PubMed ID: 19505364
[TBL] [Abstract][Full Text] [Related]
38. Physical properties and dissolution behaviour of nifedipine/mannitol solid dispersions prepared by hot melt method.
Zajc N; Obreza A; Bele M; Srcic S
Int J Pharm; 2005 Mar; 291(1-2):51-8. PubMed ID: 15707731
[TBL] [Abstract][Full Text] [Related]
39. Formulation design of carbamazepine fast-release tablets prepared by melt granulation technique.
Perissutti B; Rubessa F; Moneghini M; Voinovich D
Int J Pharm; 2003 Apr; 256(1-2):53-63. PubMed ID: 12695011
[TBL] [Abstract][Full Text] [Related]
40. Enhanced drug dissolution and bulk properties of solid dispersions granulated with a surface adsorbent.
Gupta MK; Goldman D; Bogner RH; Tseng YC
Pharm Dev Technol; 2001 Nov; 6(4):563-72. PubMed ID: 11775957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
